Charlien Berghen
Katholieke Universiteit Leuven
DissectionInternal medicineRadiologyUrologySurgerySeries (stratigraphy)OncologyBiochemical recurrenceAndrogen deprivation therapyMetastasectomyMetastasisProstatectomyProstate cancerLymph nodeRecurrent prostate cancerIn patientPost prostatectomySalvage radiationRadiation therapyTerm (time)Medicine
52Publications
6H-index
59Citations
Publications 55
Newest
#1Gaëtan Devos (Katholieke Universiteit Leuven)H-Index: 10
#2Wout Devlies (Katholieke Universiteit Leuven)H-Index: 5
Last. Wouter Everaerts (Katholieke Universiteit Leuven)H-Index: 23
view all 12 authors...
Patients with high-risk prostate cancer treated with curative intent are at an increased risk of biochemical recurrence, metastatic progression and cancer-related death compared with patients treated for low-risk or intermediate-risk disease. Thus, these patients often need multimodal therapy to achieve complete disease control. Over the past two decades, multiple studies on the use of neoadjuvant treatment have been performed using conventional androgen deprivation therapy, which comprises lute...
1 CitationsSource
#1Elio MazzoneH-Index: 11
#2Giorgio GandagliaH-Index: 47
Last. R. Jeffrey KarnesH-Index: 70
view all 25 authors...
Source
#1Valérie FonteyneH-Index: 5
#2Piet DirixH-Index: 27
Last. Piet OstH-Index: 41
view all 11 authors...
Source
#1Gert De Meerleer (Katholieke Universiteit Leuven)H-Index: 36
#2Charlien Berghen (Katholieke Universiteit Leuven)H-Index: 6
Last. Kato Rans (Katholieke Universiteit Leuven)H-Index: 2
view all 13 authors...
In patients with prostate cancer who have a high risk of pelvic nodal disease, the use of elective whole pelvis radiotherapy is still controversial. Two large, randomised, controlled trials (RTOG 9413 and GETUG-01) did not show a benefit of elective whole pelvis radiotherapy over prostate-only radiotherapy. In 2020, the POP-RT trial established the role of elective whole pelvis radiotherapy in patients who have more than a 35% risk of lymph node invasion (known as the Roach formula). POP-RT stre...
Source
1 CitationsSource
#1N. FossatiH-Index: 4
#2J.R. KarnesH-Index: 3
Last. Elio MazzoneH-Index: 11
view all 22 authors...
Source
#1Elio MazzoneH-Index: 11
#2N. FossatiH-Index: 4
Last. G. GandagliaH-Index: 3
view all 23 authors...
Source
#1N. FossatiH-Index: 4
#2Elio MazzoneH-Index: 11
Last. B. Noris ChiordaH-Index: 1
view all 24 authors...
Source
#1N. FossatiH-Index: 4
#2Elio MazzoneH-Index: 11
Last. B. Noris ChiordaH-Index: 1
view all 25 authors...
Source
#1Elio MazzoneH-Index: 11
#2N. FossatiH-Index: 4
Last. B. Noris ChiordaH-Index: 1
view all 23 authors...
Source